ContextVision Sees Strong Momentum in 2019 Across Medical Imaging and Digital Pathology Sectors
STOCKHOLM – February 20, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced solid sales in Q4 to close out a record year for the company. With sales growth across its medical imaging offerings and patent approval for its unique method for high-quality digital pathology data generation, this past quarter has set a strong foundation for the future of the company. Sales in the fourth quarter ended at 28.1 MSEK, a small increase compared to the fourth quarter in 2018. Sales in 2019 ended at 95.3 MSEK.